Stockscreener 앱 받기
6.69
2.76%
0.18
시간 외 거래:
6.71
0.02
+0.30%
전일 마감가:
$6.51
열려 있는:
$6.61
하루 거래량:
426.07K
Relative Volume:
1.02
시가총액:
$443.95M
수익:
$555.06M
순이익/손실:
$-39.48M
주가수익비율:
-11.15
EPS:
-0.6
순현금흐름:
$29.05M
1주 성능:
+3.24%
1개월 성능:
+7.90%
6개월 성능:
-42.72%
1년 성능:
-1.62%
1일 변동 폭
$6.61
$6.795
1주일 범위
$6.3341
$6.795
52주 변동 폭
$5.28
$14.38
Bioventus Inc Stock (BVS) Company Profile
명칭
Bioventus Inc
전화
(919) 474-6700
주소
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
BVS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BVS
Bioventus Inc
|
6.69 | 435.31M | 555.06M | -39.48M | 29.05M | -0.60 |
|
ABT
Abbott Laboratories
|
133.58 | 231.14B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.09 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.89 | 146.12B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.44 | 105.64B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.52 | 45.60B | 5.54B | 4.18B | 623.10M | 7.00 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-17 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2023-12-07 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-08-09 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2022-11-22 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2022-11-09 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2022-11-09 | 다운그레이드 | JP Morgan | Overweight → Underweight |
| 2022-03-15 | 개시 | Craig Hallum | Buy |
| 2021-11-15 | 재개 | Morgan Stanley | Overweight |
| 2021-11-10 | 재개 | JP Morgan | Overweight |
| 2021-07-01 | 다운그레이드 | Goldman | Buy → Neutral |
| 2021-03-08 | 개시 | Canaccord Genuity | Buy |
| 2021-03-08 | 개시 | Goldman | Buy |
| 2021-03-08 | 개시 | JP Morgan | Overweight |
| 2021-03-08 | 개시 | Morgan Stanley | Overweight |
모두보기
Bioventus Inc 주식(BVS)의 최신 뉴스
(BVS) Proactive Strategies - news.stocktradersdaily.com
Bone Growth Stimulator Market Booming Worldwide with - openPR.com
bioventus inc. reports results of annual stockholders meeting By Investing.com - Investing.com India
bioventus inc. reports results of annual stockholders meeting - Investing.com
Bioventus Holds Annual Meeting, Elects Directors - TipRanks
Cetera Investment Advisers Sells 1,805 Shares of Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus’ Cut Losses 46%, Organic Sales Up 5% - Orthopedics This Week
Millennium Management LLC Sells 60,811 Shares of Bioventus Inc. (NYSE:BVS) - Defense World
Janus Henderson Group PLC Acquires Shares of 17,200 Bioventus Inc. (NYSE:BVS) - Defense World
Balyasny Asset Management L.P. Invests $133,000 in Bioventus Inc. (NYSE:BVS) - Defense World
BNP Paribas Financial Markets Invests $1.66 Million in Bioventus Inc. (NYSE:BVS) - Defense World
Price T Rowe Associates Inc. MD Has $160,000 Stock Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
(BVS) On The My Stocks Page - news.stocktradersdaily.com
Bioventus reiterates 2025 guidance with focus on growth and profitability - MSN
Barclays PLC Has $696,000 Holdings in Bioventus Inc. (NYSE:BVS) - Defense World
Bioventus (BVS) Price Target Trimmed by Craig-Hallum Analyst | BVS Stock News - GuruFocus
Bioventus Inc. (NASDAQ:BVS) Q1 2025 Earnings Call Transcript - Insider Monkey
Is Bioventus (NASDAQ:BVS) Using Too Much Debt? - simplywall.st
Bioventus First Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures - Yahoo Finance
Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures By GuruFocus - Investing.com Canada
Bioventus Reports Q1 2025 Financial Performance - TipRanks
Bioventus: Q1 Earnings Snapshot - CTPost
Bioventus Earnings Call: Growth Amid Challenges - TipRanks
Financial Fitness Check: Examining Bioventus Inc (BVS)’s Key Ratios - DWinneX
Bioventus earnings beat by $0.04, revenue topped estimates - Investing.com Canada
Bioventus Q1 2025 slides: 5% organic growth despite revenue decline, maintains guidance - Investing.com Canada
Earnings call transcript: Bioventus Q1 2025 beats EPS forecast but faces stock dip - Investing.com Nigeria
Bioventus Inc. Q1 Loss Narrows - Nasdaq
Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Bioventus (BVS) Exceeds Q1 Revenue Expectations with Strong Perf - GuruFocus
Bioventus Inc Q1 2025 Earnings: Revenue Hits $123.9M, Beating Es - GuruFocus
Bioventus (BVS) Exceeds Q1 Revenue Expectations with Strong Performance | BVS Stock News - GuruFocus
Bioventus reports Q1 revenue and earnings above estimates, shares dip By Investing.com - Investing.com Nigeria
Bioventus reports Q1 revenue and earnings above estimates, shares dip - Investing.com Australia
Bioventus Reports First Quarter Financial Results | BVS Stock Ne - GuruFocus
Bioventus Reports First Quarter Financial Results - The Manila Times
Bioventus Reports First Quarter Financial Results | BVS Stock News - GuruFocus
Bioventus Inc. Reports Q1 2025 Financial Results: Revenue Decline of 4.3% but Organic Growth of 5.0% and Improved Non-GAAP EPS - Nasdaq
Bioventus Inc. SEC 10-Q Report - TradingView
(BVS) Trading Report - news.stocktradersdaily.com
Examining the Future: Bioventus's Earnings Outlook - Nasdaq
Bioventus Inc (BVS) Q1 2025 Earnings Report Preview: What To Look For - GuruFocus
Bioventus Inc expected to post earnings of 2 cents a shareEarnings Preview - TradingView
Legal & General Group Plc Raises Position in Bioventus Inc. (NYSE:BVS) - Defense World
Orthobiologics Market Growth Statistics & Future Prospects | Medtronic, Orthofix Medical, Bioventus - openPR.com
Bioventus Q1 2025 Earnings Preview: Key Metrics and Business Updates Coming May 6 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Bioventus Inc (BVS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Bioventus Inc 주식 (BVS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| SUTTER MARTIN P | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
85,241 |
| STALNECKER SUSAN M | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
105,957 |
| NOHRA GUY P | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
126,610 |
| NEELS GUIDO J | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
85,241 |
| McMurry-Heath Michelle | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
74,698 |
| Ladone Mary Kay | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
78,981 |
| HAWKINS WILLIAM A | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
257,851 |
| Beyer Pat | Director |
Jun 02 '25 |
Option Exercise |
0.00 |
26,493 |
0 |
76,436 |
| Singleton Mark Leonard | SVP & CFO |
Apr 11 '25 |
Sale |
7.57 |
3,875 |
29,334 |
141,088 |
| D'Adamio Anthony | SVP & General Counsel |
Apr 11 '25 |
Sale |
7.57 |
2,958 |
22,392 |
131,416 |
0.56%
0.13%
자본화:
|
볼륨(24시간):